Details for Patent: 8,003,673
✉ Email this page to a colleague
Which drugs does patent 8,003,673 protect, and when does it expire?
Patent 8,003,673 protects CUBICIN and is included in one NDA.
This patent has three patent family members in three countries.
Summary for Patent: 8,003,673
| Title: | Daptomycin for the treatment of biofilm and catheter salvage |
| Abstract: | Daptomycin can be used for biofilm treatment (particularly central venous catheter salvage for S. epidermidis infected catheters). Catheter salvage with daptomycin shows rapid cidality, activity against stationary phase bacteria, and penetration and activity in biofilms. The present inventions provide formulations, methods, and articles of manufacture useful for biofilm treatment or catheter salvage involving daptomycin. Particular formulations include daptomycin in lactated Ringer's solution having a rapid kill curve against the bacteria of the biofilm. |
| Inventor(s): | Alder; Jeffrey (Harvard, MA), Silverman; Jared (Brookline, MA), Mortin; Lawrence (Framingham, MA), Van Praagh; Andrew (Chelmsford, MA) |
| Assignee: | Cubist Pharmaceuticals, Inc. (Lexington, MA) |
| Application Number: | 11/916,089 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Device; |
Drugs Protected by US Patent 8,003,673
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cubist Pharms Llc | CUBICIN | daptomycin | POWDER;INTRAVENOUS | 021572-002 | Sep 12, 2003 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF THE FOLLOWING INFECTIONS: COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS AND STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTIONS (BACTEREMIA) INCLUDING THOSE WITH RIGHT-SIDED INFECTIVE ENDOCARDITIS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,003,673
| PCT Information | |||
| PCT Filed | May 31, 2006 | PCT Application Number: | PCT/US2006/021006 |
| PCT Publication Date: | December 07, 2006 | PCT Publication Number: | WO2006/130629 |
International Family Members for US Patent 8,003,673
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2610716 | ⤷ Sign Up | |||
| Japan | 2008546429 | ⤷ Sign Up | |||
| World Intellectual Property Organization (WIPO) | 2006130629 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
